Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Nfocus Neuromedical has completed the acquisition of StarFire Medical, a manufacturer of therapeutic implantable devices for interventional treatment of neurovascular diseases.
Subscribe to our email newsletter
The assets acquired include products such as the DSB (Detachable Silicone Balloon) and the NDSB (Non-Detachable Silicone Balloon), also known as the Endeavor Balloon Catheter, both of which have been cleared for marketing by the FDA and through CE marking in Europe. The acquisition also included other neurovascular devices and Intellectual Property (IP) of StarFire. The remaining StarFire IP is focused on advanced intracranial aneurysm treatment devices that are in development.
Martin Dieck, president and CEO of Nfocus, said: “The combination of StarFire’s existing FDA-cleared devices and advanced aneurysm cover technology fits perfectly with the Nfocus product platform.”